Sarepta Therapeutics Long Term Debt 2010-2024 | SRPT

Sarepta Therapeutics long term debt for the quarter ending September 30, 2024 was $1.136B, a 8.15% decline year-over-year.

  • Sarepta Therapeutics long term debt for 2023 was $1.133B, a 26.66% decline from 2022.
  • Sarepta Therapeutics long term debt for 2022 was $1.544B, a 40.79% increase from 2021.
  • Sarepta Therapeutics long term debt for 2021 was $1.097B, a 10.52% increase from 2020.

Sarepta Therapeutics Long Term Debt 2010-2024 | SRPT

  • Sarepta Therapeutics long term debt for 2023 was $1.133B, a 26.66% decline from 2022.
  • Sarepta Therapeutics long term debt for 2022 was $1.544B, a 40.79% increase from 2021.
  • Sarepta Therapeutics long term debt for 2021 was $1.097B, a 10.52% increase from 2020.